Evaluation of depression, anxiety and posttraumatic stress response levels of children and adolescents treated with COVID-19

Basit Öğe Kaydı
dc.contributor.authorTaskesen, Bekir
dc.contributor.authorKardas, Omer
dc.contributor.authorYilmaz, Kamil
dc.date.accessioned2024-04-24T16:01:54Z
dc.date.available2024-04-24T16:01:54Z
dc.date.issued2023
dc.departmentDicle Üniversitesien_US
dc.description.abstractWe aimed to evaluate stress level reactions to depression, anxiety, and posttraumatic stress in paediatric patients' post-COVID-19 infection. A total of two hundred consecutive patients aged 8 to 18 years were prospectively enrolled in the study between March 2020 and June 2021. One hundred patients were diagnosed with a positive COVID-PCR test and had inpatient management. Another hundred patients had positive COVID-PCR results and completed their care and isolation for 14 days at home. We used the child posttraumatic stress reaction index (CPTS-RI), child depression inventory (CDI), and screen for child anxiety-related disorders (SCARED) to evaluate their post-COVID-19 infection mental health state. In the study population, the mean age was 13.4 years, and 50.5% were male. Sixty-seven patients were paediatric, and the rest were adolescents. Based on our scaling system, 10% of patients had depression. Forty-one percent of patients had at least one high subscale of SCARED. Forty-four percent of patients' CPTS-RI was above the normal limit, while 4% had a severe stress reaction level. In the female patient population, SCARED and CPTS-RI were significantly high (p = 0.01). There was no significant correlation between hospitalization duration and test scores. The CPTS-RI score was significantly higher in the outpatient group than in the other groups (p = 0.01). The inpatient group had significantly higher social phobia, while the outpatient group had significantly higher school phobia (p = 0.01 and p = 0.05, respectively). Conclusion: The present study showed that COVID-19 infection is a significant risk factor for psychopathology in children and adolescents.en_US
dc.identifier.doi10.1007/s00431-022-04713-3
dc.identifier.endpage574en_US
dc.identifier.issn0340-6199
dc.identifier.issn1432-1076
dc.identifier.issue2en_US
dc.identifier.pmid36383286
dc.identifier.scopus2-s2.0-85141968353
dc.identifier.scopusqualityQ1
dc.identifier.startpage567en_US
dc.identifier.urihttps://doi.org/10.1007/s00431-022-04713-3
dc.identifier.urihttps://hdl.handle.net/11468/14468
dc.identifier.volume182en_US
dc.identifier.wosWOS:000884617200004
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdolescenten_US
dc.subjectAnxietyen_US
dc.subjectCovid-19en_US
dc.subjectDepressionen_US
dc.subjectMental Healthen_US
dc.titleEvaluation of depression, anxiety and posttraumatic stress response levels of children and adolescents treated with COVID-19en_US
dc.titleEvaluation of depression, anxiety and posttraumatic stress response levels of children and adolescents treated with COVID-19
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu